SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: Global Pulmonary Drug Delivery Systems Market 2013-2019: Metered Dose Inhalers, Dry Powder Inhalers and Nebulizers

[May 12, 2014]

Research and Markets: Global Pulmonary Drug Delivery Systems Market 2013-2019: Metered Dose Inhalers, Dry Powder Inhalers and Nebulizers

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/78grt8/pulmonary_drug) has announced the addition of the "Global Pulmonary Drug Delivery Systems Market 2013-2019: Metered Dose Inhalers, Dry Powder Inhalers and Nebulizers" report to their offering.

The market size and forecast for each region has been provided for the period 2011 to 2019 along with the CAGR (%) for the forecast period 2013 to 2019. The study also includes qualitative analysis of the competitive scenario in these regions. The market overview section of the report comprises qualitative analysis of the overall market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter's five force analysis and market attractiveness analysis.

This report studies the current scenario as well as the future market potential for pulmonary drug delivery systems, globally. The market for pulmonary drug delivery systems has been segmented into three major product types, namely, metered dose inhalers (MDIs), dry powder inhalers (DPIs) and nebulizers.


The market for these systems has been extensively analyzed on the basis of factors such as therapeutic application, geographic presence and technological developments. On the basis of therapeutic application, the market has been segmented into asthma, chronic obstructive pulmonary disease (COPD) and cystic fibrosis. The market size and forecasts in terms of revenue (USD million) for each of these segments have been provided for the period 2011 to 2019, considering 2012 as the base year. The report also provides the compounded annual growth rate (CAGR) for each segment of the market for the forecast period 2013 to 2019.

The report also provides a section on the competitive landscape of the market, wherein the market share analysis of leading players in the global pulmonary drug delivery systems market, in terms of percentage share in 2012 has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and accentuate market shares.

Scope

Pulmonary Drug Delivery Systems Market, by Product Type

  • Metered Dose Inhalers (MDIs)
  • Dry Powder Inhalers (DPIs)
  • Nebulizers

Pulmonary Drug Delivery Systems Market, by Application

  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Cystic Fibrosis

Companies Mentioned

  • 3M (News - Alert) Health Care
  • Allied Healthcare Products, Inc.
  • AstraZeneca plc
  • Boehringer Ingelheim
  • CareFusion Corporation
  • GF Health Products, Inc.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG
  • Omron Healthcare, Inc.
  • PARI Respiratory Equipment, Inc.
  • Philips (News - Alert) Healthcare
  • Sunovion Pharmaceuticals Inc.

For more information visit http://www.researchandmarkets.com/research/78grt8/pulmonary_drug


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved.